The Newcastle upon Tyne Hospitals NHS Foundation Trust (NUTH) is one of the busiest, largest and most successful teaching NHS foundation trusts in the country, with 14,000 staff and an annual income of £1billion.
Rated ‘Outstanding’ by the Care Quality Commission (CQC) in 2019, we have a long history of providing high quality care, clinical excellence, and innovation in medical research regionally, nationally and internationally.
We’re also proud to be the second largest provider of specialised services in the country and support people with a range of rare and complex medical, surgical and neurological conditions, cancers and genetic orders.
‘Outstanding’ service profile
Our staff oversee around 1.84m patients ‘contacts’ each year, delivering high standards of healthcare from the following sites:
- Freeman Hospital
- Royal Victoria Infirmary (RVI)
- Campus for Ageing and Vitality (the former Newcastle General Hospital site)
- Newcastle Dental Hospital
- Newcastle Fertility Centre
- Northern Genetics Service
- Cramlington Manor Walks
These include a range of flagship services which deliver cutting-edge care (supported by state-of-the-art diagnostic services in both radiology and pathology) and are a catalyst for innovation to support pioneering clinical practice in the NHS:
- The Cardiothoracic Centre – providing complex cardiopulmonary surgery, including heart and lung transplants for both children and adults, with some of the best clinical outcomes in the country
- The Northern Centre for Cancer Care – one of the country’s most advanced centres providing state-of-the-art cancer care and highly specialised chemotherapy and radiotherapy treatments including Stereotactic Radiosurgery (SRS) for malignant and benign tumours
- The Institute of Transplantation – where the first successful heart transplant on a child was carried out - as well as the first single and dual lung transplants in Europe, liver, kidney and pancreas transplantation
Royal Victoria Infirmary:
- The Great North Children’s Hospital – providing a full range of children’s health services where we are recognised as one of the leading clinical research units in Europe for paediatric immunology and infectious diseases, and home to one of only two units in the country where children with severe immune system problems can be treated in an air tight isolation ward
- The Great North Trauma and Emergency Centre – one of two trauma centres serving the Northern Trauma network which extends from the Scottish Borders to Yorkshire and is supported by the regional neurosciences centre, burns unit and other specialist trauma-related expertise
- Our Breast Cancer Service – the UK’s sole provider of Iodine-125 seeds as an alternative to guide wires to localise tumours in the breast and lymph nodes
The Trust is also at the forefront of pioneering treatments such as mitochondrial donation at the Centre for Life - a form of IVF in which the future baby’s mitochondrial DNA comes from a donor egg to avoid passing on inherited diseases – and PrEP (Pre-exposure prophylaxis, a drug to prevent HIV).
Furthermore our patients, both children and adults, will be amongst the first in the world to receive CAR-T cell therapy which marks a new era of personalised medicine for treating lymphoma and leukaemia.
Leaders in research and development
We are leaders in healthcare research and development across a wide range of specialisms delivering benefits not only for today’s patients but for generations to come. We work in partnership with Newcastle University in key areas which are important to all our futures including stem cell research, genetics, ageing and vitality.
Much of our work is underpinned by a world-class programme of research and innovation for which we have an enviable reputation. This has been strengthened through our partnerships with the North East and North Cumbria Academic Health Science Network, National Institute for Health Research, Northern Health Science Alliance and Newcastle Academic Health Partners – a collaboration between the Trust, Northumberland, Tyne and Wear NHS Foundation Trust and Newcastle University which focuses on improving the health and opportunities for people living in Newcastle and the surrounding area.
We are also proud of our new and existing partnerships with local people, patients, neighbouring NHS organisations, universities, local authority and charitable bodies.
Top of the League
For the seventh consecutive year (2017/18), our organisation topped the National Institute of Health Research (NIHR) research activity league table with 18,773 patients participating in research studies, including 964 participants in commercial research studies.
Newcastle Hospitals is one of 11 NIHR Medtech and Invitro Diagnostics Co-operatives (MICs), leading to the launch of ‘Diagnostics North East’ – an overarching structure bringing together all the components of a unique and innovative diagnostics infrastructure to aid diagnostic development for industry and academia.
The NIHR Biomedical Research Centre in Ageing & Long-Term Conditions was also recently renewed and continues to provide infrastructure for the considerable volume of high quality, leading edge research in ageing and long-term conditions.
The parallel brand to Diagnostics North East, known as Therapeutics North East, also received a £7million grant for a National Advanced Treatment Centres for Cellular Therapies, a project being delivered in partnership with centres in Scotland.
In 2017 we were proud to be awarded Global Digital Exemplar (GDE) status based upon our past investment and adoption of technology as part of our drive to continually improve quality of care and patient safety.
In 2016 the Newcastle Hospitals was commissioned to manage the national atypical Haemolytic Uraemic Syndrome (aHUS) service delivering a fully integrated pathway to expedite optimal management of patients with this rare condition on a shared-care basis with referring clinicians.
Chief Executive: Dame Jackie Daniel